Mo Chen

1.5k citations

50 papers · 932 indexed · h-index 17

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Drug Discovery top 10%

Papers in ⓘ

Reproductive Medicine 13
- Ovarian cancer diagnosis and treatment 9
- Endometriosis Research and Treatment 4
Obstetrics and Gynecology 9
- Uterine Myomas and Treatments 7
- Endometrial and Cervical Cancer Treatments 5

Co-authors: T.M. Penning (3 shared papers)Liangqing Yao (10 shared papers)Adegoke O. Adeniji (1 shared paper)Jie Wu (3 shared papers)Liangqing Yao (11 shared papers)Danqing Zheng (1 shared paper)Congjian Xu (3 shared papers)Yifeng He (3 shared papers)
Journals: Orthopaedic Journal of Sports Medicine (3 papers)International Journal of Gynecological Cancer (3 papers)Organic Chemistry Frontiers (2 papers)Journal of Translational Medicine (2 papers)Medicine (2 papers)
Partner nations: China United States Portugal

In The Last Decade

Mo Chen

45 papers receiving 928 citations

Peers

Countries citing papers authored by Mo Chen

Since Specialization

Citations

This map shows the geographic impact of Mo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Chen more than expected).

Fields of papers citing papers by Mo Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Chen. The network helps show where Mo Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Mo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mo Chen Line = papers co-authored together Mo Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	AKR1C3 as a target in castrate resistant prostate cancer The Journal of Steroid Biochemistry and Molecular Biology ·Adegoke O. Adeniji, Mo Chen, T.M. Penning	2013	118
2	The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer Oncotarget ·Yifeng He, Qiujing Zhu, Mo Chen, Qihong Huang, Wenjing Wang, Qing Li, Yuting Huang, Wen Di	2016	96
3	Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3 Signal Transduction and Targeted Therapy ·Haoting Sun, Chaoqun Wang, Beiyuan Hu, Xiaomei Gao, Tiantian Zou, Qin Luo, Mo Chen, Yan Fu, Yuan‐Yuan Sheng, Kaili Zhang, Yan Zheng, Xudong Ren, Shican Yan, Yan Geng, Luyu Yang, Qiongzhu Dong, Lun–Xiu Qin	2021	88
4	A general route to sulfones via insertion of sulfur dioxide promoted by cobalt oxide Organic Chemistry Frontiers ·Danqing Zheng, Mo Chen, Liangqing Yao, Jie Wu	2016	76
5	miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1 International Journal of Molecular Medicine ·Haosha Tang, Liangqing Yao, Xiang Tao, Yi Yu, Mo Chen, Rong Zhang, Congjian Xu	2013	58
6	Synthesis of sulfonated naphthols via C–H bond functionalization with the insertion of sulfur dioxide Organic Chemistry Frontiers ·Kaida Zhou, Mo Chen, Liangqing Yao, Jie Wu	2017	53
7	Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1 Biochemical and Biophysical Research Communications ·Jiajia Li, Xiuling Zhi, Xiaoqing Shen, Chen Chen, Lei Yuan, Xuhui Dong, Chenqi Zhu, Liangqing Yao, Mo Chen	2019	49
8	The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia Journal of Experimental & Clinical Cancer Research ·Pengfei Zhu, Yanxia Ning, Liangqing Yao, Mo Chen, Congjian Xu	2010	45
9	Isorenieratene interaction with human serum albumin: Multi-spectroscopic analyses and docking simulation Food Chemistry ·Yashu Chen, Yufeng Zhou, Mo Chen, Bijun Xie, Jifang Yang, Jigang Chen, Zhida Sun	2018	42
10	Detoxication of Structurally Diverse Polycyclic Aromatic Hydrocarbon (PAH) o-Quinones by Human Recombinant Catechol-O-methyltransferase (COMT) via O-Methylation of PAH Catechols Journal of Biological Chemistry ·Li Zhang, Yi Jin, Mo Chen, Meng Huang, Ronald G. Harvey, Ian A. Blair, T.M. Penning	2011	28
11	SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway Aging ·Mo Chen, Jia Zeng, Shuyi Chen, Jiajia Li, Huijie Wu, Xuhui Dong, Lei Yuan, Xiuling Zhi, Liangqing Yao	2020	25
12	CDK9 inhibitor CDKI-73 is synergetic lethal with PARP inhibitor olaparib in BRCA1 wide-type ovarian cancer. PubMed ·Jiajia Li, Xiuling Zhi, Shuyi Chen, Xiaoqing Shen, Chen Chen, Lei Yuan, Jieyu Guo, Dan Meng, Mo Chen, Liangqing Yao	2020	25
13	Patient Outcomes and Fear of Returning to Sports After Arthroscopic Bankart Repair With Remplissage Orthopaedic Journal of Sports Medicine ·Sijia Feng, Mo Chen, Jun Chen, Hong Li, Jiwu Chen, Shiyi Chen	2021	22
14	Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer Journal of Translational Medicine ·Zhuowei Gu, Yifeng He, Yue Zhang, Mo Chen, Keqi Song, Yuting Huang, Qing Li, Wen Di	2018	21
15	Magnesium alloy covered stent for treatment of a lateral aneurysm model in rabbit common carotid artery: An in vivo study Scientific Reports ·Wu Wang, Yongli Wang, Mo Chen, Liang Chen, Jian Zhang, Yong-Dong Li, Ming‐Hua Li, Guangyin Yuan	2016	20
16	Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer Frontiers in Immunology ·Ruoyao Zou, Qidi Jiang, Tianqiang Jin, Mo Chen, Liangqing Yao, Hongda Ding	2022	19
17	Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival BMC Cancer ·Rui-Xue Cui, Na Liu, Qing-Mei He, Wen-Fei Li, Bi-Jun Huang, Ying Sun, Ling‐Long Tang, Mo Chen, Ning Jiang, Lei Chen, Jing‐Ping Yun, Jing Zeng, Ying Guo, Hui‐Yun Wang, Jun Ma	2012	18
18	Anti-Tumor Efficiency of Perillylalcohol/β-Cyclodextrin Inclusion Complexes in a Sarcoma S180-Induced Mice Model Pharmaceutics ·Allan Andrade Rezende, Rafael Silva Santos, Luciana Nalone Andrade, Ricardo Guimarães Amaral, Matheus M. Pereira, Cristiane Bani, Mo Chen, Ronny Priefer, Classius Ferreira da Silva, Ricardo Luiz Cavalcanti de Albuquerque Júnior, Eliana B. Souto, Patrícia Severino	2021	14
19	The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer Disease Markers ·Jiajia Li, Xiuling Zhi, Yating Sun, Mo Chen, Liangqing Yao	2022	12
20	Feasibility of radical hysterectomy in women with FIGO stage IIB cervical cancer: an observation study of 10-year experience in a tertiary center OncoTargets and Therapy ·Lei Yuan, Jiaqi Guo, Xiaochun Zhang, Mo Chen, Congjian Xu, Liangqing Yao	2018	9

About Mo Chen

Mo Chen is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Otorhinolaryngology, Cancer Research and Surgery, having authored 50 papers that have together received 932 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Uterine Myomas and Treatments (7 papers), Endometrial and Cervical Cancer Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), Endometriosis Research and Treatment (4 papers), Reconstructive Surgery and Microvascular Techniques (4 papers), Shoulder Injury and Treatment (3 papers) and Catalytic C–H Functionalization Methods (3 papers). The work is most often cited by research in Cancer Research (209 citations), Drug Discovery (2 citations), Cell Biology (107 citations), Reproductive Medicine (53 citations) and Organic Chemistry (177 citations). Mo Chen has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include T.M. Penning, Liangqing Yao, Adegoke O. Adeniji, Jie Wu, Liangqing Yao, Danqing Zheng, Congjian Xu, Yifeng He, Qing Li and Wen Di. Their work appears in journals such as Orthopaedic Journal of Sports Medicine, International Journal of Gynecological Cancer, Organic Chemistry Frontiers, Journal of Translational Medicine and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact